ClinicalTrials.gov
public full text
Public Domain
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
This is a prospective, randomized clinical trial to investigate the clinical impact of a preemptive pharmacogenomics strategy to guide antidepressant therapy in cancer patients. Those enrolled onto the clinical trial will be randomized to either DNA-guided choice of therapy or clinical management alone. Scores on self-reported measures of depressive and anxiety symptoms along with quality of life will be compared between cohorts.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm#967300
- pharmacology of antidepressants#24633
- Rhodiola Rosea Therapy of Major Depressive Disorder#843112
- The Registry of Oncology Outcomes Associated With Testing and Treatment#463715
- AZD6765 for Treatment Resistant Depression#1126527
Record · ID 1058478
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive